Aratana Therapeutics (PETX) Return on Assets ROA from the first quarter of 2019 to first quarter of 2018 and for the year 2019, Average High and Low, Fundamental Ratios from Mar 31 2019 to Mar 31 2018 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Aratana Therapeutics, Inc.  (PETX)


Aratana Therapeutics's ROA from the first quarter of 2019 to the first quarter of 2018 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Aratana Therapeutics's ROA in the first quarter of 2019?
Aratana Therapeutics, Inc. recorded a cumulative net loss of $-13 million during 12 months ending in the first quarter of 2019, resulting in a negative return on assets (ROA) of -10.83%.

However, within the Healthcare sector 285 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2019 quarter, so far to 3725, from total ROA ranking in the fourth quarter of 2018 at 4142.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter		 (Mar 31 2018)
I. Quarter
Y / Y Total Assets Change -22.25 % -21.27 % -3.59 % -16.2 % 0.01 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -13 -15 -22 -39 -43
Return On Assets (TTM) -10.83 % -11.57 % -16.13 % -29.06 % -30.62 %
PETX's Total Ranking # 3725 # 4142 # 3822 # 4103 # 4201
Total Assets (TTM) in million 105 106 140 128 135
Seq. Total Assets Change -1.62 % -23.87 % 9.24 % -4.97 % -0.38 %
Seq. Net Income Change - - - - -

PETX's 5 Years Annual ROA >> Back to PETX Management Effectiveness >> Compare PETX ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 95
Sector # 286
Overall # 3562

Return On Assets Statistics
High Average Low
143.79 %
-10.08 %
-61.88 %
(Dec 31 2013)   (Mar 31 2016)





Financial Statements
Aratana Therapeutics's Assets $ 105 million PETX's Balance sheet
Aratana Therapeutics's Income $ -7 million Quarterly PETX's Income Statement
PETX's Income by Division See PETX's Income by Division



Annual Return On Assets (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016		 (Dec 31 2015)
FY 2015		 (Dec 31 2014)
FY 2014
Y / Y Total Assets Change -21.27 % -10.63 % 2.86 % -29.26 % 79.95 %
Total Assets in million 106 135 151 147 208
Y / Y Net Income Change - - - - -
Net Income in million -15 -48 -34 -84 -39
Annual Return On Assets -13.83 % -35.14 % -22.2 % -57.15 % -18.67 %

PETX's 5 Years Annual ROA >> Back to PETX Management Effectiveness >> Compare PETX ROA to its Competitors



More Return On Assets Ratios
PETX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PETX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PETX's Competitors
Subscribers only: Roa for Aratana Therapeutics's Suppliers
Subscribers only: Return On Assets for PETX's Customers

You may also want to know
PETX's Roi PETX's Inventory Turnover Ratio PETX's Growth Rates PETX's Dividend Comparisons
PETX's Profitability Ratios PETX's Asset Turnover Ratio PETX's Dividend Growth
PETX's Roe PETX's Valuation Ratios PETX's Financial Strength Ratios PETX's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2019, within Healthcare Sector ROA

Date modified: 2026-09-08T15:22:04+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.